ATARA BIOTHERAPEUTICS INC's ticker is ATRA and the CUSIP is 046513107. A total of 147 filers reported holding ATARA BIOTHERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.02 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $2,849,198 | -5.8% | 868,658 | +8.6% | 0.00% | 0.0% |
| Q3 2022 | $3,023,085 | -51.5% | 799,758 | 0.0% | 0.00% | -50.0% |
| Q2 2022 | $6,230,115 | -31.3% | 799,758 | -18.0% | 0.00% | 0.0% |
| Q1 2022 | $9,065,721 | -41.1% | 975,858 | 0.0% | 0.00% | -33.3% |
| Q4 2021 | $15,380,000 | +14.5% | 975,858 | +30.0% | 0.00% | 0.0% |
| Q3 2021 | $13,436,000 | +11.8% | 750,614 | -2.9% | 0.00% | 0.0% |
| Q2 2021 | $12,022,000 | +1.6% | 773,147 | -6.2% | 0.00% | 0.0% |
| Q1 2021 | $11,838,000 | -55.6% | 824,362 | -39.3% | 0.00% | -50.0% |
| Q4 2020 | $26,642,000 | -4.8% | 1,357,222 | -37.1% | 0.01% | -14.3% |
| Q3 2020 | $27,979,000 | +5.8% | 2,158,846 | +18.9% | 0.01% | -12.5% |
| Q2 2020 | $26,457,000 | +209.7% | 1,815,828 | +80.9% | 0.01% | +166.7% |
| Q1 2020 | $8,542,000 | -48.3% | 1,003,746 | 0.0% | 0.00% | -40.0% |
| Q4 2019 | $16,532,000 | +16.6% | 1,003,746 | 0.0% | 0.01% | +25.0% |
| Q3 2019 | $14,173,000 | -26.5% | 1,003,746 | +4.7% | 0.00% | -33.3% |
| Q2 2019 | $19,280,000 | -18.4% | 958,746 | +61.3% | 0.01% | -25.0% |
| Q1 2019 | $23,625,000 | +14.4% | 594,345 | 0.0% | 0.01% | 0.0% |
| Q4 2018 | $20,648,000 | +8.3% | 594,345 | +28.9% | 0.01% | +33.3% |
| Q3 2018 | $19,066,000 | +144.1% | 461,093 | +116.9% | 0.01% | +100.0% |
| Q2 2018 | $7,811,000 | -5.8% | 212,540 | 0.0% | 0.00% | 0.0% |
| Q1 2018 | $8,289,000 | +31.8% | 212,540 | -38.8% | 0.00% | +50.0% |
| Q4 2017 | $6,289,000 | -4.8% | 347,442 | -13.0% | 0.00% | -33.3% |
| Q3 2017 | $6,606,000 | +18.2% | 399,155 | 0.0% | 0.00% | +50.0% |
| Q2 2017 | $5,588,000 | -4.2% | 399,155 | +40.6% | 0.00% | 0.0% |
| Q1 2017 | $5,834,000 | +44.7% | 283,882 | 0.0% | 0.00% | 0.0% |
| Q4 2016 | $4,031,000 | +57.5% | 283,882 | +126.7% | 0.00% | +100.0% |
| Q3 2016 | $2,559,000 | +184.0% | 125,240 | +213.0% | 0.00% | – |
| Q2 2016 | $901,000 | +18.4% | 40,010 | 0.0% | 0.00% | – |
| Q1 2016 | $761,000 | -28.0% | 40,010 | 0.0% | 0.00% | -100.0% |
| Q4 2015 | $1,057,000 | -16.0% | 40,010 | 0.0% | 0.00% | 0.0% |
| Q3 2015 | $1,258,000 | -4.7% | 40,010 | +60.0% | 0.00% | 0.0% |
| Q2 2015 | $1,320,000 | +26.9% | 25,010 | 0.0% | 0.00% | 0.0% |
| Q1 2015 | $1,040,000 | +2.5% | 25,010 | -34.1% | 0.00% | 0.0% |
| Q4 2014 | $1,015,000 | – | 37,932 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Antipodean Advisors LLC | 800,000 | $11,656,000 | 5.38% |
| Consonance Capital Management LP | 5,238,218 | $76,321,000 | 4.57% |
| BRIDGER MANAGEMENT, LLC | 1,785,784 | $26,019,000 | 2.41% |
| Trellus Management Company, LLC | 150,000 | $2,186,000 | 2.37% |
| MAVERICK CAPITAL LTD | 6,754,102 | $98,407,000 | 2.07% |
| Redmile Group, LLC | 6,843,370 | $99,708,000 | 1.84% |
| Baupost Group | 9,922,030 | $144,564,000 | 1.80% |
| Camber Capital Management LP | 1,400,000 | $20,398,000 | 1.17% |
| Pinz Capital Management, LP | 161,100 | $2,347,000 | 1.08% |
| Artal Group S.A. | 2,500,000 | $36,425,000 | 1.02% |